Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to 67.03%.

  • Bio Key International's EBITDA Margin fell 367700.0% to 67.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.87%, marking a year-over-year increase of 20500.0%. This contributed to the annual value of 61.68% for FY2024, which is 447900.0% up from last year.
  • As of Q3 2025, Bio Key International's EBITDA Margin stood at 67.03%, which was down 367700.0% from 65.33% recorded in Q2 2025.
  • In the past 5 years, Bio Key International's EBITDA Margin registered a high of 26.25% during Q1 2024, and its lowest value of 386.84% during Q4 2022.
  • In the last 5 years, Bio Key International's EBITDA Margin had a median value of 96.42% in 2024 and averaged 108.75%.
  • As far as peak fluctuations go, Bio Key International's EBITDA Margin skyrocketed by 3473200bps in 2021, and later plummeted by -1729900bps in 2022.
  • Over the past 5 years, Bio Key International's EBITDA Margin (Quarter) stood at 213.85% in 2021, then crashed by -81bps to 386.84% in 2022, then skyrocketed by 68bps to 122.45% in 2023, then rose by 21bps to 96.42% in 2024, then skyrocketed by 30bps to 67.03% in 2025.
  • Its last three reported values are 67.03% in Q3 2025, 65.33% for Q2 2025, and 45.41% during Q1 2025.